Screener
vTv Therapeutics VTVT Q1 2026 earnings
Reported May 13, 2026 · Before market open
Revenue$36.8MBeat by $16.8M
EPS$1.65Beat by $1.31
Revenue estimate$20.0M
EPS estimate$0.34
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$333.3K
EPS estimate-$1.15
Versus estimates
Revenue
Q1 2026$36.8MBeat by $16.8M
Diluted EPS
FAQ
- When did vTv Therapeutics report Q1 2026 earnings?
- vTv Therapeutics (VTVT) reported Q1 2026 earnings on May 13, 2026 before market open.
- What were vTv Therapeutics's Q1 2026 revenue and EPS?
- vTv Therapeutics reported revenue of $36.8M and eps of $1.65 for Q1 2026.
- Did vTv Therapeutics beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $20.0M by $16.8M. EPS beat the consensus estimate of $0.34 by $1.31.
- Where can I find vTv Therapeutics's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001641489-26-000019) and the 10-Q periodic report (0001641489-26-000020) directly on SEC EDGAR. The filing index links above go to sec.gov.
